Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia

Blood

Volumn 95, Issue 11, 2000, Pages 3534-3540

  Sahota, Surinder S ^a   Davis, Zadie ^a   Hamblin, Terry J ^a   Stevenson, Freda K ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 6;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLONING; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; GENE LOCUS; GERMINAL CENTER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION;

EID: 0034210246     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3534     Document Type: Article

References (31)

1. Honjo T, Alt FW, eds. Immunoglobulin Genes. 2nd ed. London, UK: Academic Press; 1995.
2. Berek C. The development of B cells and the B cell repertoire in the microenvironment of the germinal centre, Immunol Rev. 1992;126:5-19.
3. Steele EJ, ed. Somatic Hypermutation in V-regions. Boca Raton, FL: CRC Press; 1991.
4. Stevenson F, Sahota S, Zhu D, et al. Insight into the origin and clonal history of B-cell tumours as revealed by analysis of immunoglobulin variable region genes, Immunol Rev. 1998;162:247-259.
5. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1-8.
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
7. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
8. H genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 1997;89:4153-4160.
9. Schettino EW, Cerutti A, Chiorazzi N, Casali P. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CDS+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol. 1998;160:820-830.
10. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA. 1995;92:12,520-12,524.
11. Bardwell VJ, Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 1994;8:1664-1677.
12. Ye BH, Rao PH, Chaganti RS, Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma Cancer Res. 1993;53:2732-2735.
13. Catoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood. 1995;86:45-53.
14. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet. 1997; 16:161-170.
15. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6. in diffuse large-cell lymphoma. Science. 1993;262:747-750.
16. Ye BH, Chaganti S, Chang C-C, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 1995;14:6209-6217.
17. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998; 95:11,816-11,821.
18. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutations of Ig genes. Science. 1998;280:1750-1752.
19. Peng H-Z, Du M-Q, Koulis A, et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 1999;93:2167-2172.
20. Kwok S, Higuchi R. Avoiding false positives with PCR Nature. 1989;339:237-238.
21. H gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood. 1996;87:746-755.
22. Capello D, Vitolo U. Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 2000;95: 651-659.
23. Losses IS, Levy R. Mutation analysis of the 5′ noncoding regulatory region of the bcl-6 gene in non-Hodgkin's lymphoma: evidence for intraclonal heterogeneity. Blood. 1999;94(suppl 1): 58a.
24. Rothwell DG, Kalakonda N, Scarffe JH, Norton JD. Tumour cell population dynamics in multiple myeloma: analysis of N-Ras and Bcl-6 mutations. Blood. 1999;94(suppl 1):543a.
25. Cesarman E, Chadburn A, Liu Y-F, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood. 1998;92:2294-2302.
26. Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the BCL6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med. 1994; 331:74-80.
27. Liang R, Chan WP, Kwong YL, et al. BCL-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin. Br J Haematol. 1997;99: 668-670.
28. Gaidano G, Carbone A, Pastore C, et al. Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood. 1997;89:3755-3762.
29. Nakamura Y, Saito K, Furusawa S. Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma. Br J Haematol. 1999; 105:274-277.
30. Flenghi L, Bigerna B, Fizzotti M, et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein aminoterminal region. Am J Pathol. 1996;48:1543-1555.
31. Falini B, Fizzotti M, Pileri S, Liso A, Pasqualucci L, Flenghi L. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol. 1997;8(suppl 2):101-104.